Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Japanese giants like MUFG, Nidec, and Polyplastics are setting up tech centres in India. Driven by an ageing population and China risk, they aim to tap India's deep talent pool for AI, cybersecurity, and engineering. Read more.
Himachal's apple growers fear the India-New Zealand trade agreement will flood the market with cheap imports, destroying their livelihoods. Read the full story on the looming crisis.
New Zealand PM Christopher Luxon hails the historic Free Trade Agreement with India as a major boost for jobs, exports, and economic growth. Key details inside.
Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.
Tired of unpredictable flight prices? Learn how to use Skyscanner's three key tools—Explore Everywhere, Price Alerts, and Flexible Dates—to find the cheapest air tickets effortlessly. Start saving on travel today!
Nxtcell India appoints Atul Vivek as CEO effective Jan 1, 2026. With 20 years of leadership experience from Realme, Samsung, and others, he will drive Alcatel's smartphone and AIoT expansion. Read more.
Shark Tank India Season 5 premieres Jan 5, 2026, with new sharks joining the panel. Get all details on judges, timing, and where to watch the business reality show.
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
New data shows semaglutide reduces major heart events by 20%, independent of weight loss. This breakthrough offers new hope for India's early-onset heart disease patients. Learn more.
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Indian companies plan a major hiring surge in 2026, creating 10-12 million jobs. Driven by tech and diversity goals, firms like EY, Tata Motors, and Diageo are expanding teams. Read the full outlook.
India's auto sector ended 2025 with robust growth. JSW MG, Mahindra, Kia & Skoda reported record sales, driven by EVs and strong demand. Get all the key figures and insights here.
India imposes 11-12% safeguard duty on select steel imports for three years to protect domestic industry from cheap shipments, primarily from China. Read the full details.
A US-based vlogger's heartfelt goodbye video from India, filmed on a two-wheeler, goes viral. He shares how the country's warmth and daily life changed his perspective. Read his emotional journey.
Air India Express launches a massive PayDay Sale with domestic fares from ₹1,850 and international from ₹5,355. Book on app for no fees. Sale valid until Jan 2026.
Massive discounts bring premium 53-inch smart TVs from Sony, TCL, and Realme down to the price of smaller 32-inch models. Find out where and how to grab this limited-time offer before it ends.
As India enters 2026, it faces critical tests in trade talks with the US, volatile neighbours, and balancing great-power ties. This analysis explores Delhi's strategic choices in a fractured world.
After a turbulent 2025 marked by conflict and trade wars, India enters 2026 with crucial choices on Pakistan, US ties under Trump, and key summits. Explore the high-stakes diplomatic roadmap ahead.
A comprehensive look at the biggest smartphone launches in India for 2025, featuring Samsung, Apple, Google, OnePlus, Xiaomi, and more. Discover the flagships and budget kings that defined the year.
Dreaming of a European holiday without the hefty price tag? Discover 9 stunning countries where you can experience rich history, beautiful landscapes, and delicious food on an Indian traveller's budget.
Ajanta Pharma partners with Biocon to market weight-loss drug semaglutide in 26 markets. Deal expected to add ₹200 crore sales by FY28, enhancing its branded generics focus. Read more.
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
A look back at India's 2025: navigating US tariffs, sealing key trade pacts, expanding in West Asia, and facing military confrontation with Pakistan. Explore the year's diplomatic highs and lows.
Govt Medical College Hospital in Kochi offers crucial cancer diagnosis and immunohistochemistry tests at very low rates, helping around 1300 patients yearly. Learn about this vital healthcare initiative.
Explore Bengaluru's famous budget markets like Chickpet and Commercial Street for affordable fabrics, tech, and souvenirs. Discover where to shop without breaking the bank.